Siga Technologies Inc (SIGA): Cash & Equivalents
$154.97M
As of 2025-12-31
$117.58M
As of 2026-06-30
+16.2%
3-year compound annual growth
+5.6%
5-year compound annual growth
+3.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $154.97M | -0.3% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $155.40M | +3.5% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $150.15M | +52.0% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $98.79M | -4.2% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $103.14M | -12.5% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $117.89M | +80.7% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $65.25M | -35.2% | 2022-03-03, Balance as of period end |
| 2018-12-31 | $100.65M | +406.9% | 2021-03-04, Balance as of period end |
| 2017-12-31 | $19.86M | -30.8% | 2020-03-05, Balance as of period end |
| 2016-12-31 | $28.70M | -74.5% | 2019-03-06, Balance as of period end |
| 2015-12-31 | $112.71M | +13.0% | 2018-03-06, Balance as of period end |
| 2014-12-31 | $99.71M | +9.2% | 2017-03-07, Balance as of period end |
| 2013-12-31 | $91.31M | +185.2% | 2016-03-04, Balance as of period end |
| 2012-12-31 | $32.02M | -35.0% | 2015-03-06, Balance as of period end |
| 2011-12-31 | $49.26M | +677.9% | 2014-03-10, Balance as of period end |
| 2010-12-31 | $6.33M | -56.3% | 2013-05-15, Balance as of period end |
| 2009-12-31 | $14.50M | n/a | 2012-03-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Siga Technologies Inc (SIGA) | 2025-12-31 | $154.97M | -0.3% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $122.52M | +29.2% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $120.86M | -27.5% |
| Zymeworks Inc. (ZYME) | 2025-12-31 | $41.16M | -37.7% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $41.32M | -18.7% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $62.41M | +84.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $246.96M | +124.5% |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $167.81M | +344.0% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $230.91M | -2.6% |
Compare SIGA, CYTK, LAB, ZYME side by side · Screen every company in Pharmaceutical Preparations ↗